oleanolic acid has been researched along with Alzheimer Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basile, L; Copani, A; Giuffrida, ML; Guccione, S; Merlo, S; Sortino, MA | 1 |
| Guo, Q; He, J; Li, H; Yao, L; Zhang, H | 1 |
| Berté, TE; Bürger, C; Cechinel-Filho, V; Dalmagro, AP; de Souza, MM; Dos Santos, DA; Gonçalves, AE; Meyre-Silva, C; Weber, CJ; Zimath, PL | 1 |
| Guo, W; Liu, S; Sun, W; Wang, K; Xu, J; Zhang, L; Zhang, Y; Zhou, Z | 1 |
| Wang, S; Xu, Y; Yang, H; Yu, L; Zhu, X | 1 |
| Ahn, YJ; Kwon, HW; Na, YE; Perumalsamy, H; Wang, X | 1 |
| Adcott, J; Bertrand, HC; Callard, R; Castillo-Quan, JI; Cochemé, HM; Gatliff, J; Gomez Perez-Nievas, B; Ivanov, DK; Kerr, F; Khericha, M; Martinez, P; Noble, W; Partridge, L; Snoeren, I; Sofola-Adesakin, O; Thornton, J; Wells, G | 1 |
| Calingasan, NY; Dumont, M; Flint Beal, M; Gouras, GK; Liby, K; Lin, MT; Nathan, C; Sporn, M; Tampellini, D; Wille, E; Williams, C | 1 |
| Hu, YZ; Li, P; Xu, L; Yang, ZL; Zhou, YQ | 1 |
| Chen, XL; Hu, HT; Liu, Y; Qian, YH; Ren, HM; Xu, JH | 1 |
10 other study(ies) available for oleanolic acid and Alzheimer Disease
| Article | Year |
|---|---|
Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity.
Topics: Alzheimer Disease; Cell Cycle; Cell Death; Cell Division; DNA Polymerase beta; DNA Replication; Enzyme Inhibitors; Flavones; Humans; Molecular Structure; Neurons; Neuroprotective Agents; Parkinson Disease | 2015 |
Oleanolic acid alleviates oxidative stress in Alzheimer's disease by regulating stanniocalcin-1 and uncoupling protein-2 signalling.
Topics: Alzheimer Disease; Cell Line; Glycoproteins; Humans; Oleanolic Acid; Oxidative Stress; Signal Transduction; Uncoupling Protein 2 | 2020 |
Taraxerol as a possible therapeutic agent on memory impairments and Alzheimer's disease: Effects against scopolamine and streptozotocin-induced cognitive dysfunctions.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Avoidance Learning; Cognitive Dysfunction; Male; Maze Learning; Memory; Oleanolic Acid; Rats; Rats, Wistar; Scopolamine; Streptozocin | 2018 |
Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer's Disease Model Rats by Maintaining Synaptic Plasticity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antipsychotic Agents; Avoidance Learning; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Electric Stimulation; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Microscopy, Electron, Transmission; Oleanolic Acid; Peptide Fragments; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synapses; Synaptic Potentials | 2018 |
Esculentoside A suppresses Aβ(1-42)-induced neuroinflammation by down-regulating MAPKs pathways in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Astrocytes; Disease Models, Animal; Down-Regulation; Encephalitis; Hippocampus; Inflammation Mediators; Male; MAP Kinase Signaling System; Memory; Mice; Mice, Inbred C57BL; Microglia; Oleanolic Acid; Peptide Fragments; Saponins | 2015 |
Effects and possible mechanisms of action of acacetin on the behavior and eye morphology of Drosophila models of Alzheimer's disease.
Topics: Agastache; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Animals, Genetically Modified; Behavior, Animal; Disease Models, Animal; Drosophila; Eating; Eye; Flavones; Fluorescence Resonance Energy Transfer; Gene Expression Regulation; Humans; Longevity; Male; Oleanolic Acid; Phenotype; Triterpenes | 2015 |
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Gene Expression Profiling; Glycogen Synthase Kinase 3; Humans; Kelch-Like ECH-Associated Protein 1; Lithium Chloride; Longevity; Mice; Microscopy, Confocal; Neurons; NF-E2-Related Factor 2; Oleanolic Acid; Peptide Fragments; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Thiadiazoles; Triazoles | 2017 |
Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cricetinae; Disease Models, Animal; Female; Memory; Memory Disorders; Mice; Mice, Transgenic; Oleanolic Acid; Plaque, Amyloid; Triterpenes | 2009 |
Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-beta induced cytotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Cell Survival; Cytoprotection; Dipsacaceae; Drugs, Chinese Herbal; L-Lactate Dehydrogenase; Oleanolic Acid; PC12 Cells; Rats; Saponins | 2009 |
The effects of the total saponin of Dipsacus asperoides on the damage of cultured neurons induced by beta-amyloid protein 25-35.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Brain; Cell Death; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Hippocampus; Hydro-Lyases; Lipid Peroxidation; Malondialdehyde; Neurons; Neuroprotective Agents; Oleanolic Acid; Oxidative Stress; Peptide Fragments; Rats; Saponins; Tetrazolium Salts; Thiazoles | 2002 |